🇺🇸 FDA
Pipeline program

Lysogenic HSV virus.

2024-2497

Phase 1 mab active

Quick answer

Lysogenic HSV virus. for HNSCC is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
HNSCC
Phase
Phase 1
Modality
mab
Status
active

Clinical trials